Evolva Holding SA (EVE.SW)

CHF 0.84

(-6.44%)

Net Debt Summary of Evolva Holding SA

Evolva Holding SA's latest annual net debt in 2023 was -5.83 Million CHF , down -158.89% from previous year.
Evolva Holding SA's latest quarterly net debt in 2024 Q2 was -7.15 Million CHF , down 0.0% from previous quarter.
Evolva Holding SA reported annual net debt of 9.91 Million CHF in 2022, up 6246.87% from previous year.
Evolva Holding SA reported annual net debt of -161.3 Thousand CHF in 2021, up 98.48% from previous year.
Evolva Holding SA reported quarterly net debt of -5.83 Million CHF for 2023 FY, down -158.89% from previous quarter.
Evolva Holding SA reported quarterly net debt of -5.83 Million CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Net Debt of Evolva Holding SA (2023 - 2005)

Year	Net Debt	Net Debt Growth
2023	-5.83 Million CHF	-158.89%
2022	9.91 Million CHF	6246.87%
2021	-161.3 Thousand CHF	98.48%
2020	-10.64 Million CHF	68.49%
2019	-33.79 Million CHF	40.93%
2018	-57.2 Million CHF	39.15%
2017	-94 Million CHF	-118.74%
2016	-42.97 Million CHF	44.99%
2015	-78.12 Million CHF	-47.59%
2014	-52.93 Million CHF	-188.49%
2013	-18.34 Million CHF	-3397.55%
2012	-524.6 Thousand CHF	97.18%
2011	-18.59 Million CHF	44.66%
2010	-33.59 Million CHF	22.57%
2009	-43.38 Million CHF	-18.97%
2008	-36.46 Million CHF	39.65%
2007	-60.42 Million CHF	7.32%
2006	-65.19 Million CHF	46.74%
2005	-122.42 Million CHF	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-7.15 Million CHF	0.0%
2023 FY	-5.83 Million CHF	-158.89%
2023 Q4	-5.83 Million CHF	0.0%
2023 Q2	12.32 Million CHF	0.0%
2022 Q4	9.91 Million CHF	0.0%
2022 Q2	4.94 Million CHF	0.0%
2022 FY	9.91 Million CHF	6246.87%
2021 Q4	-161.3 Thousand CHF	0.0%
2021 Q2	1.22 Million CHF	0.0%
2021 FY	-161.3 Thousand CHF	98.48%
2020 FY	-10.64 Million CHF	68.49%
2020 Q2	-19.61 Million CHF	0.0%
2020 Q4	-10.64 Million CHF	0.0%
2019 Q2	-38.69 Million CHF	0.0%
2019 FY	-33.79 Million CHF	40.93%
2019 Q4	-33.79 Million CHF	0.0%
2018 Q2	-71.42 Million CHF	0.0%
2018 Q4	-57.2 Million CHF	0.0%
2018 FY	-57.2 Million CHF	39.15%
2017 FY	-94 Million CHF	-118.74%
2017 Q4	-94 Million CHF	0.0%
2017 Q2	-29.55 Million CHF	0.0%
2016 Q4	-42.97 Million CHF	0.0%
2016 Q2	-61.86 Million CHF	0.0%
2016 FY	-42.97 Million CHF	44.99%
2015 Q4	-78.12 Million CHF	0.0%
2015 FY	-78.12 Million CHF	-47.59%
2015 Q2	-38.76 Million CHF	0.0%
2014 FY	-52.93 Million CHF	-188.49%
2014 Q2	-53.78 Million CHF	0.0%
2014 Q4	-52.93 Million CHF	0.0%
2013 Q4	-18.19 Million CHF	0.0%
2013 Q2	-23.36 Million CHF	0.0%
2013 FY	-18.34 Million CHF	-3397.55%
2012 Q2	-6.42 Million CHF	0.0%
2012 Q4	-524.6 Thousand CHF	0.0%
2012 FY	-524.6 Thousand CHF	97.18%
2011 Q4	-18.59 Million CHF	0.0%
2011 FY	-18.59 Million CHF	44.66%
2011 Q2	-20.72 Million CHF	0.0%
2010 Q2	-39.04 Million CHF	0.0%
2010 FY	-33.59 Million CHF	22.57%
2010 Q4	-33.59 Million CHF	0.0%
2009 Q4	-43.38 Million CHF	0.0%
2009 FY	-43.38 Million CHF	-18.97%
2008 FY	-36.46 Million CHF	39.65%
2007 FY	-60.42 Million CHF	7.32%
2006 FY	-65.19 Million CHF	46.74%
2005 FY	-122.42 Million CHF	0.0%

Peer Net Debt Comparison of Evolva Holding SA

Name	Net Debt	Net Debt Difference
Addex Therapeutics Ltd	-3.52 Million CHF	-65.818%
BB Biotech AG	304.39 Million CHF	101.918%
Basilea Pharmaceutica AG	116.11 Million CHF	105.028%
Idorsia Ltd	1.05 Billion CHF	100.552%
Kuros Biosciences AG	-8.69 Million CHF	32.811%
Molecular Partners AG	-183.23 Million CHF	96.814%
Relief Therapeutics Holding AG	-10.24 Million CHF	43.009%
Santhera Pharmaceuticals Holding AG	-5.3 Million CHF	-9.998%